Cargando…
Advancing digital health: FDA innovation during COVID-19
Digital health products have played an important role in the COVID-19 response, from supporting the remote monitoring of patients to enabling continuity in data collection for clinical trials. The U.S. Food and Drug Administration (FDA) has issued a number of temporary policies to support digital he...
Autores principales: | Kadakia, Kushal, Patel, Bakul, Shah, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747714/ https://www.ncbi.nlm.nih.gov/pubmed/33335250 http://dx.doi.org/10.1038/s41746-020-00371-7 |
Ejemplares similares
-
Digital biomarkers: Convergence of digital health technologies and biomarkers
por: Vasudevan, Srikanth, et al.
Publicado: (2022) -
FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine
por: Luh, Frank, et al.
Publicado: (2018) -
Ulcer pressure prevention and opportunity for innovation during the COVID-19 crisis
por: Nani, Fernando Souza, et al.
Publicado: (2020) -
A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic
por: Frenk, Julio, et al.
Publicado: (2022) -
Promises and perils of the FDA's over-the-counter naloxone reclassification
por: Zhu, David T., et al.
Publicado: (2023)